15 results
424B3
EVOK
Evoke Pharma Inc
14 Mar 24
Prospectus supplement
6:44pm
be material, we could incur reputational damage and the further development and commercialization of our product candidate could be delayed … may not be sufficient to cover the financial, legal, business or reputational losses that may result from an interruption or breach of our systems
PRE 14A
ow4hi 3w7su6mf
12 Mar 21
Preliminary proxy
8:30am
424B5
dximg8mi6u5cz
22 Jul 16
Prospectus supplement for primary offering
12:00am
424B5
8s9j 7hyy4
20 Jul 16
Prospectus supplement for primary offering
12:00am
DEF 14A
fyt8pe2w
8 Apr 14
Definitive proxy
12:00am
424B4
g2vqc ad6ilbdn8w0
25 Sep 13
Prospectus supplement with pricing info
12:00am
- Prev
- 1
- Next